SEARCH

SEARCH BY CITATION

Keywords:

  • mortality prediction;
  • risk adjustment;
  • emergency medicine;
  • sepsis

Abstract

  1. Top of page
  2. Abstract
  3. References

Objectives: A patient's baseline health status may affect the ability to survive an acute illness. Emergency medicine research requires tools to adjust for confounders such as comorbid illnesses. The Charlson Comorbidity Index has been validated in many settings but not extensively in the emergency department (ED). The purpose of this study was to examine the utility of the Charlson Index as a predictor of one-year mortality in a population of ED patients with suspected infection.

Methods: The comorbid illness components of the Charlson Index were prospectively abstracted from the medical records of adult (age older than 18 years) ED patients at risk for infection (indicated by the clinical decision to obtain a blood culture) and weighted. Charlson scores were grouped into four previously established indices: 0 points (none), 1–2 points (low), 3–4 points (moderate), and ≥5 points (high). The primary outcome was one-year mortality assessed using the National Death Index and medical records. Cox proportional-hazards ratios were calculated, adjusting for age, gender, and markers of 28-day in-hospital mortality.

Results: Between February 1, 2000, and February 1, 2001, 3,102 unique patients (96% of eligible patients) were enrolled at an urban teaching hospital. Overall one-year mortality was 22% (667/3,102). Mortality rates increased with increasing Charlson scores: none, 7% (95% confidence interval [CI] = 5.4% to 8.5%); low, 22% (95% CI = 19% to 24%); moderate, 31% (95% CI = 27% to 35%); and high, 40% (95% CI = 36% to 44%). Controlling for age, gender, and factors associated with 28-day mortality, and using the “none” group as a reference group, the Charlson Index predicted mortality as follows: low, odds ratio of 2.0; moderate, odds ratio of 2.5; and high, odds ratio of 4.7.

Conclusions: This study suggests that the Charlson Index predicts one-year mortality among ED patients with suspected infection.

References

  1. Top of page
  2. Abstract
  3. References
  • Jencks SF, Dobson A. Refining case-mix adjustment: the research evidence. N Engl J Med. 1987; 317:67986.
  • Greenfield S, Aronow HV, Elashoff RM, Watanaba D. Flaws in mortality data: the hazards of ignoring comorbid disease. JAMA. 1988; 260:22535.
  • Charlson ME, Pompei P, Ales KL, MacKenzie RC. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40:37383.
  • 4. How to measure comorbidity: a critical review of available methods. J Clin Epidemiol. 2003; 56:2219.
  • Navarro-Cano G, Del Rincon I, Pogosian S, Roldan JF, Escalante A. Association of mortality with disease severity in rheumatoid arthritis, independent of comorbidity. Arthritis Rheum. 2003; 48:242533.
  • Sin DD, McAlister FA. The effects of beta-blockers in morbidity and mortality in a population-based cohort of 11,942 elderly patients with heart failure. Am J Med. 2002; 113:6506.
  • Yu DT, Black E Sands KE, et al. Severe sepsis: variation in resource and therapeutic modality among academic centers. Crit Care. 2003; 7(3):2434.
  • Durairaj L, Will JG, Torner JC, Doebbleling BN. Prognostic factors for mortality following interhospital transfers to the medical intensive care unit of a tertiary referral center. Crit Care Med. 2003; 31:19816.
  • Yu DT, Platt R Lanken PN, et al. Relationship of pulmonary artery catheter use to mortality and resource utilization in patients with severe sepsis. Crit Care Med. 2003; 31:273441.
  • Tu JV, Austin PC Johnston KW. The influence of surgical specialty training on the outcomes of elective abdominal aortic aneurysm surgery. J Vasc Surg. 2002; 33:44752.
  • Zacks SL, Sandler RS, Rutledge R, Brown RS. A population-based cohort study comparing laparoscopic cholecystectomy and open cholecystectomy. Am J Gastroenterol. 2002; 97:33440.
    Direct Link:
  • Collins AJ, Weinhandl E, Snyder JJ, Chen SC, Gilbertson D. Comparison and survival of hemodialysis and peritoneal dialysis in the elderly. Semin Dial. 2002; 15:98102.
  • Rozental TD, Branas CC, Bozentka DL, Beredjklian PK. Survival among elderly patients after fractures of the distal radius. J Hand Surg [Am]. 2002; 27:94852.
  • Cin MH, Goldman L. Gender differences in 1-year survival and quality of life among patients admitted with congestive heart failure. Med Care. 1998; 36:103346.
  • Gabriel SE, Crowson CS O'Fallon WM. Mortality in rheumatoid arthritis: have we made an impact in 4 decades? J Rheumatol. 1999; 26:252933.
  • Covinsky KE, Kahana E, Chin MH, Palmer RM, Fortinsky RH, Landefeld CS. Depressive symptoms and 3-year mortality in older hospitalized medical patients. Ann Intern Med. 1999; 130:5639.
  • Gabbe BJ, Magtengaard K, Hannaford AP, Cameron PA. Is the Charlson Index useful for predicting trauma outcomes? Acad Emerg Med. 2005; 12:31821.
  • Shapiro NI, Wolfe RE, Moore RB, Smith E, Burdick E, Bates DW. Mortality in Emergency Department Sepsis (MEDS) score: a prospectively derived and validated clinical rule. Crit Care Med. 2003; 31:6705.
  • SAS/STAT User's Guide Version 8.. Cary , NC : SAS Institute, 2000.
  • Liu JH, Zingmond D Etzioni DA, et al. Characterizing the performance and outcomes of obesity surgery in California. Am Surg. 2003; 69:8238.
  • Zhang Q, Safford M Ottenweller J, et al. Performance status of health care facilities changes with risk adjustment of HbA1c. Diabetes Care. 2000; 23:91927.
  • Wang PS, Solomon DH, Mogun H, Avorn J. HMG-COA reductase inhibitors and the risk of hip fractures in elderly patients. JAMA. 2000; 283:32116.
  • Monane M, Kanter DS, Glynn RJ, Avorn J. Variability in length of hospitalization for stroke. The role of managed care in an elderly population. Arch Neurol. 1996; 53:87580.
  • Winkelmayer WC, Glynn RJ, Lebin R, Mittleman MA, Pliskin JS, Avorn J. Late nephrologist referral and access to renal transplantation. Transplantation. 2002; 73:191823.
  • Filit H, Hill JW Futterman R. Health care utilization and costs of Alzheimer's disease: the role of co-morbid conditions, disease stage, and pharmacotherapy. Fam Med. 2002; 34:52835.
  • Fischer LR, Defor TA Cooper S, et al. Pharmaceutical care and health care utilization in an HMO. Effect Clin Pract. 2002; 5(2):4957.
  • Saigal CS, Pashos CL, Henning JM, Litwin MS. Variations in use of imaging in a national sample of men with early-stage prostate cancer. Urology. 2002; 59:4004.
  • Jaeger TM, Lohr RH Pankratz VS. Symptom-triggered therapy for alcohol withdrawal syndrome in medical inpatients. Mayo Clin Proc. 2001; 76:695701.
  • Martin BC, Ricci JF, Kotzan JA, Lang K, Menzin J. The net cost of Alzheimer disease and associated disorders. Alzheimer Dis Assoc Disord. 2000; 14:1519.
  • Chaung KH, Covinsky KE, Sands LP, Fortinsky RH, Palmer RM, Landefeld CS. Diagnosis-related-group-adjusted hospital costs are higher in older medical patients with lower functional status. J Am Geriatr Soc. 2003; 51:172934.
  • Phillips Bute B, Matthew J Blumenthal JA, et al. Female gender is associated with impaired quality of life 1 year after coronary artery bypass surgery. Psychosom Med. 2003; 65:94451.
  • Deyo RA, Cherkin DC Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992; 45:6139.
  • Romano PS, Roos LL Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol. 1993; 46:10759.
  • Poses RM, McClish DK, Smith WR, Bekes C, Scott WE. Prediction of survival of critically ill patients by admission comorbidity. J Clin Epidemiol. 1996; 49:7437.
  • Romano PS, Roos LL Jollis JG. Further evidence concerning the use of a clinical comorbidity index with ICD-9-CM administrative data. J Clin Epidemiol. 1993; 46:108590.
  • Ghali WA, Hall RE, Rosen AK, Ash AS, Moskowitz MA. Searching for an improved clinical comorbidity index for use in ICD-9-CM administrative data. J Clin Epidemiol. 1996; 49:2738.
  • 37. Risk adjustment for older hospitalized persons: a comparison of two methods of data collection for the Charlson index. J Clin Epidemiol. 2001; 54:694701.
  • D'Hoore W, Bouckaert A Tilquin C. Practical considerations on the use of the Charlson comorbidity index. J Clin Epidemiol. 1996; 49:142933.
  • Kieszak SM, Flanders WD, Kosinski AS, Ship CC, Karp H. A comparison of the Charlson comorbidity index derived from medical record data and administrative billing data. J Clin Epidemiol. 1999; 52:13742.
  • Cleves MA, Sanchez N Draheim M. Evaluation of two competing methods for calculating Charlson's comorbidity index when analyzing short-term mortality using administrative data. J Clin Epidemiol. 1997; 50:9038.
  • 41. How to adjust for comorbidity in survival studies in ESRD patients: a comparison of different indices. Am J Kidney Dis. 2002; 40:829.
  • Librero J, Peiro S Ordinana R. Chronic comorbidity and outcomes of hospital care: length of stay, mortality, and readmission at 30 and 365 days. J Clin Epidemiol. 1999; 52:1719.
  • D'Hoore W, Sicotte C Tilquin C. Risk adjustment in outcome assessment: the Charlson comorbidity index. Methods Inf Med. 1993; 32:3827.
  • Sachdev M, Sun JL, Tsiatis AA, Nelson CL, Mark DB, Jollis JG. The prognostic importance of comorbidity for mortality in patients with stable coronary artery disease. J Am Coll Cardiol. 2004; 43:57682.
  • Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994; 47:124551.
  • Liu M, Domen K Chino N. Comorbidity measures for stroke outcome research: a preliminary study. Arch Phys Med Rehabil. 1997; 78:16672.
  • Newschaffer CJ, Bush TL, Penberthy LE, Bellatoni M, Helzlsour K, Diener-West M. Does comorbid disease interact with cancer? An epidemiologic analysis of mortality in a cohort of elderly breast cancer patients. J Gerontol. 1998; 53:3728.
  • Beddhu S, Bruns FJ, Saul M, Seddon P, Zeidel ML. A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients. Am J Med. 2000; 108:60913.
  • Beddhu S, Zeidel ML Saul M, et al. The effects of comorbid conditions on the outcomes of patients undergoing peritoneal dialysis. Am J Med. 2002; 112:696701.
  • Rochon PA, Katz JN Morrow LA, et al. Comorbid illness is associated with survival and length of hospital stay in patients with chronic disability. Med Care. 1996; 34:1093101.
  • Gabriel SE, Crowson CS O'Fallon WM. A comparison of two comorbidity instruments in arthritis. J Clin Epidemiol. 1999; 52:13742.
  • Birim O, Zuydendorp HM, Maat AP, Kappetein AP, Eijkmans MJ, Bogers AJ. Lung resection for non-small cell lung cancer in patients older than 70: mortality, morbidity, and late survival compared with the general population. Ann Thorac Surg. 2003; 76:1796801.
  • Skiest DJ, Rubinstein E, Carley N, Gioiella L, Lyons R. The importance of comorbidity in HIV-infected patients over 55: a retrospective case-control study. Am J Med. 1996; 101:60511.
  • Schneeweiss S, Maclure M. Use of comorbidity scores for control of confounding in studies using administrative data. Int J Epidemiol. 2000; 29:8918.